120 likes | 379 Views
PLIVA, a Member of the Teva Group Tihomir Oreskovic President of the Management Board, Pliva Croatia Ltd. October, 2013. About TEVA – Strong Foundations. 111 years in existence. $20.3B 2012 revenues. $5.35 2012 EPS. 73 manufacturing sites. Over 46,000 employees. 60 countries.
E N D
PLIVA, a Member of the Teva Group Tihomir Oreskovic President of the Management Board, Pliva Croatia Ltd. October, 2013 Croatia & SEE
About TEVA – Strong Foundations 111years in existence $20.3B2012 revenues $5.352012 EPS 73 manufacturing sites Over46,000employees 60countries 70Btablets and capsules per annum 55,000+SKUs 1,000molecules Croatia & SEE
Core Strenghts Leading healthcare provider Balanced business model Manufacturing strengths Integrated R&D Entrepreneurial employees and culture Go-to-market capabilities Partnering experience 3 Croatia & SEE
PLIVA in Croatia – Pharma Leader in SEE • PLIVA, a member of the Teva Group (since 2008). • Established in 1921 • The largest pharmaceutical company in Croatia and one of the leading pharma companies in SEE • generics • inovative products and therapies (Copaxone...) • regional partnerships • One of major exporters in Croatia • >80% for export (30% Russia; 25% USA) • 2000 employees in Croatia Croatia & SEE
Working from Croatia RUSSIA CANADA ASIA EU USA JAPAN LATAM SAR Over 60 locations worldwide Croatia & SEE
Croatia -Strategically Important Production Site for TEVA • New investment cycle in production • Teva is investing $200M+ in Croatia (2011 – 2014) • Significant expansion of production capacities in Zagreb • Construction of a new manufacturing plant and supporting facilities in Savski Marof • Vertically integrated production • highly sophisticated products FDA approved - regularly audited by the FDA (since 1965), EMEA and other • Higly qualified employees • Knowledge and best practice sharing Croatia & SEE
Operations Croatia Complying with the highest global quality standardsMarkets: US, EMIA, EU; >80% for export (30% Russia; 25% USA) $100M+construction of Sterile and Oral Solid Forms facilities Technology driven manufacturing site Significantly increased production capacities 80% for exports Capacity 10B tabs Croatia & SEE
TAPI Croatia - World’s Largest AZI Supplier Chemical development center (98% for exports) Markets: US, EMIA, EU, JP, CA, LATAM $100M+the construction of the state-of-the-art facilities Investment in integrated environmental protection ($20M) Supplying 90 % of AZI demand on regulated markets 100 % increase in production capacities Croatia & SEE
PLIVA’s R&D Center of Excellence • R&D Croatia - holder of Teva's strategy for the development of complex products and NTEs 200+ highly skilled employees in R&D Experience and knowledge in development of complex projects Understanding of regulatory requirements: EU, US, CAN, EMIA, ASIA... One of the biggest users of the R&D tax incentives in Croatia Croatia & SEE
Beyond Production and R&D SSC Zagreb IT SSC Finance SSC Pharmakovigilance Communications Procuirment Business development Regulatory Quality Legal HR Regional & Global support • Providing services to different sites/countries in EU, EMIA, Asia, Americas Croatia & SEE
Working with Croatian Companies – Capabilities, Potentials and Opportunities • Croatia • located in the heart of Central Europe • the leading market for SEE region, • highly skilled and educated people • average salaries below the EU average • EU member July 2013 • Competitive incentives, R&D, employment capital Croatia & SEE